Sakai Ai, Iino Kenji, Ueda Hideyasu, Yamamoto Yoshitaka, Takemura Hirofumi
Department of Cardiovascular Surgery, Kanazawa University, Takaramachi 13-1, Kanazawa, 920-8641, Japan.
J Cardiothorac Surg. 2024 Dec 31;19(1):695. doi: 10.1186/s13019-024-03228-2.
Acute type A aortic dissection (A-AAD) with severe acute aortic regurgitation (AR) and coronary involvement is a potentially fatal condition that causes left ventricular volume overload and catastrophic acute myocardial infarction. We present the successful management of a patient using Impella 5.5 following cardiopulmonary arrest caused by A-AAD with severe acute AR and left main trunk (LMT) obstruction.
A 50-year-old man presented with acute anterior chest pain. The patient subsequently experienced a cardiac arrest, and veno-arterial extracorporeal membrane oxygenation (VA-ECMO) was administered accordingly. Contrast-enhanced computed tomography indicated type A aortic dissection extending from the sinotubular junction to the left common iliac artery. Transthoracic echocardiography revealed inversion of the aortic flap into the left ventricular outflow tract, resulting in acute severe AR and LMT obstruction. Based on these findings, the patient was diagnosed with A-AAD accompanied by severe acute AR and LMT obstruction. Emergent total arch replacement with a frozen elephant trunk (FET) was performed. However, the patient could not be weaned from cardiopulmonary bypass owing to cardiogenic shock, necessitating the introduction of VA-ECMO. Pulmonary capillary wedge pressure remained high at 22 mmHg. Subsequently, Impella 5.5 was introduced via a branch of the vascular graft to address the extensive myocardial damage due to preoperative LMT obstruction, acute AR-induced left ventricular volume overload, and increased afterload from VA-ECMO. The patient's cardiac function gradually improved. VA-ECMO and Impella 5.5 were weaned on postoperative day 8 and 20, respectively. However, three months postoperatively, a MitraClip was used to progress secondary mitral regurgitation associated with left ventricular remodeling after myocardial infarction. The patient gradually recovered from the neurological deficit and was transferred for physical rehabilitation five months postoperatively.
The patient exhibited severe cardiac dysfunction due to extensive myocardial infarction and acute AR from A-AAD. Retrograde perfusion via VA-ECMO was required for systemic organ perfusion but was expected to hinder cardiac recovery. This report demonstrates that Impella effectively aids the restoration of cardiac function in such desperate conditions.
急性A型主动脉夹层(A-AAD)合并严重急性主动脉瓣关闭不全(AR)及冠状动脉受累是一种潜在的致命疾病,可导致左心室容量超负荷及灾难性急性心肌梗死。我们报告了1例因A-AAD合并严重急性AR及左主干(LMT)阻塞导致心脏骤停后使用Impella 5.5成功救治的病例。
一名50岁男性因急性前胸痛就诊。患者随后发生心脏骤停,随即给予静脉-动脉体外膜肺氧合(VA-ECMO)治疗。增强计算机断层扫描显示A型主动脉夹层从窦管交界延伸至左髂总动脉。经胸超声心动图显示主动脉瓣叶翻转至左心室流出道,导致急性严重AR及LMT阻塞。基于这些发现,患者被诊断为A-AAD合并严重急性AR及LMT阻塞。急诊行带冻结象鼻(FET)的全主动脉弓置换术。然而,由于心源性休克,患者无法脱离体外循环,因此需要使用VA-ECMO。肺毛细血管楔压维持在22 mmHg的高水平。随后,通过血管移植物的一个分支置入Impella 5.5,以解决术前LMT阻塞、急性AR引起的左心室容量超负荷以及VA-ECMO导致的后负荷增加所引起的广泛心肌损伤。患者的心功能逐渐改善。VA-ECMO和Impella 5.5分别在术后第8天和第20天撤离。然而,术后3个月,使用MitraClip治疗心肌梗死后左心室重构相关的继发性二尖瓣反流。患者神经功能缺损逐渐恢复,术后5个月转至康复机构进行身体康复治疗。
该患者因A-AAD导致广泛心肌梗死和急性AR,出现严重心脏功能障碍。通过VA-ECMO进行逆行灌注以维持全身器官灌注,但预计会阻碍心脏功能恢复。本报告表明,在这种危急情况下,Impella能有效辅助心脏功能恢复。